Edition:
United States

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

63.50CHF
22 Sep 2017
Change (% chg)

CHF-0.20 (-0.31%)
Prev Close
CHF63.70
Open
CHF63.60
Day's High
CHF63.65
Day's Low
CHF63.10
Volume
75,999
Avg. Vol
110,651
52-wk High
CHF64.00
52-wk Low
CHF43.65

Chart for

About

BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s... (more)

Overall

Beta: 1.14
Market Cap(Mil.): CHF3,517.90
Shares Outstanding(Mil.): 55.40
Dividend: 2.75
Yield (%): 4.33

Financials

  Industry Sector
P/E (TTM): -- 81.40 16.08
EPS (TTM): -- -- --
ROI: -- 3.18 14.60
ROE: -- 4.93 14.03

BRIEF-BB Biotech reports 5.1 pct passive stake in Intra-Cellular Therapies

* BB Biotech AG reports 5.1 percent passive stake in Intra-Cellular Therapies Inc as of August 18, 2017 - SEC filing‍​ Source text: (http://bit.ly/2xcLrz4) Further company coverage:

Aug 23 2017

BRIEF-BB Biotech H1 net result turns to profit of CHF 478 mln

* ‍CONSEQUENTLY, H1 2017 NET INCOME AMOUNTED TO CHF 478 MN, COMPARED TO A LOSS OF CHF 1 170 MN FOR H1 2016​

Jul 21 2017

BRIEF-BB Biotech posts Q1 net profit of 375 million Swiss francs

* Earned a bottom-line profit of 375 million Swiss francs ($375.45 million) in Q1 of 2017

Apr 21 2017

Earnings vs. Estimates